Direct Healthcare Costs by Level of Adherence of a Real-World Population of Statin Users in Italy.
Luca Degli EspostiChiara VeronesiDomenica Daniela AnconaMargherita AndrettaFausto BartoliniAlberto DreiAlessandro LupiStefano PalcicDavide ReFrancesca Vittoria RizziElisa GiacominiValentina PerronePublished in: ClinicoEconomics and outcomes research : CEOR (2022)
The study highlighted a decrease in overall mean costs as adherence levels increase, particularly for patients with previous CV events, showing how improving adherence could be associated to cost savings and suggesting suited strategy based on CV profile should be undertaken for adherence optimization.